Cell-based paracrine mechanism

Cell-based paracrine mechanisms refer to a therapeutic approach where the clinical benefit is derived from the secretion of various bioactive molecules by administered cells, rather than through a single, defined molecular target interaction (Gnecchi et al., 2016, Methods in Molecular Biology). This phenomenon is frequently observed in mesenchymal stem cell (MSC) therapies, where the secretome—comprising cytokines, chemokines, and extracellular vesicles—modulates the local microenvironment to promote tissue repair and immune regulation (Liang et al., 2014, Stem Cell Research & Therapy). Because the therapeutic effect results from a complex mixture of factors acting on multiple pathways simultaneously, identifying a singular receptor or enzyme as the target is often not possible with current analytical methods (Teixeira et al., 2013, Journal of Stem Cell Research & Therapy). This classification is typically used in drug development databases to categorize therapies that demonstrate efficacy in vivo but lack a characterized molecular mechanism of action. Such mechanisms are central to regenerative medicine and are being explored for conditions ranging from myocardial infarction to autoimmune disorders.

Other names

Paracrine signaling mechanismCell-mediated paracrine effectBystander effectSecretome-mediated therapyNon-target-specific cell signaling

Therapeutic effect is achieved through the secretion of a cocktail of bioactive molecules, including cytokines, chemokines, growth factors, and extracellular vesicles, which act on neighboring cells to modulate the microenvironment and induce physiological changes without binding to a single defined molecular target.